| NGX Limited (NGX) ORDINARY FULLY PAID |
Materials |
$9 |
June 2025 Quarterly Report
|
30 Jul 2025 9:16AM |
$0.150 |
$0.100 |
fallen by
33.33%
|
|
NGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Operational review of key NGX projects and assets.
- Summary of exploration and production results for the quarter.
- Disclosure of financial performance, including revenues and expenditures.
- Updates on capital investment and project development progress.
- Future outlook and strategic initiatives for NGX Limited.
- Corporate governance and compliance matters.
- Environmental and sustainability initiatives and commitments.
- Discussion of market trends and regulatory developments affecting NGX.
- Stakeholder engagement and communication efforts.
- Risk management practices and business continuity planning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saturn Metals Limited (STN) ORDINARY FULLY PAID |
Materials |
$274 |
Application for quotation of securities - STN
|
30 Jul 2025 9:15AM |
$0.405 |
$0.500 |
risen by
23.46%
|
|
| Core Lithium Ltd (CXO) ORDINARY FULLY PAID |
Materials |
$939 |
Quarterly Activities and Cashflow Report
|
30 Jul 2025 9:14AM |
$0.105 |
$0.290 |
risen by
176.19%
|
|
CXO - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities up to 31 March 2023
- First spodumene concentrate production achieved at Finniss Lithium Project
- Initial shipments of spodumene concentrate generate first revenue
- Operational ramp-up and commissioning progress reported
- No lost time injuries and workforce growth highlighted
- Significant drilling and exploration activities ongoing at Finniss and surrounding tenements
- Offtake agreements and customer relations updated
- Cash balance and financial summary provided
- Capital expenditure and net cash flow disclosed
- Plans for additional exploration, drilling, and project development in subsequent quarters
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$56 |
Appendix 4C & Quarterly Update
|
30 Jul 2025 9:14AM |
$0.170 |
$0.073 |
fallen by
57.06%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon Therapeutics Limited (ASX:NUZ) provided its Appendix 4C quarterly cash flow report and business update for the period ending 31 March 2024.
- The company is focused on developing CNS (central nervous system) drugs and currently advancing its lead program, NRZ-101, for the treatment of Post-Traumatic Stress Disorder (PTSD).
- During the quarter, Neurizon worked towards the submission of an Investigational New Drug (IND) application to the US FDA for NRZ-101, targeting a first-in-human clinical trial in PTSD.
- Significant progress was made in preclinical studies and manufacturing activities, with the company on track to submit the IND in the second half of 2024.
- Neurizon continues to engage with key opinion leaders, clinicians, and patient advocacy groups to support its clinical development plans.
- The company reported total cash outflows from operating activities of $1.8 million for the quarter, with $13.6 million cash on hand at quarter-end.
- No payments to related parties or their associates were made during the period, other than standard remuneration.
- Neurizon is evaluating strategic opportunities for pipeline expansion and partnerships to maximize the value of its CNS portfolio.
- The company remains well funded to execute on its near-term milestones, including advancing NRZ-101 into clinical development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Briscoe Group Australasia Limited (BGP) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$847 |
BGP - Disclosure Notices Filed with NZX
|
30 Jul 2025 9:13AM |
$5.450 |
$3.800 |
fallen by
30.28%
|
|
| Lark Distilling Co. Ltd (LRK) ORDINARY FULLY PAID |
Consumer Staple |
$92 |
June 2025 Quarterly Update and Appendix 4C
|
30 Jul 2025 9:13AM |
$0.850 |
$0.860 |
risen by
1.18%
|
|
LRK - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly update covering operational and financial highlights for the period ending June 2025.
- Discussion of production milestones and increases in distillation capacity.
- Brand development activities, including marketing and new product launches.
- Sales performance summary, with focus on growth in key markets.
- Details of cash flows including receipts, manufacturing costs, and administration outlays.
- Strategic initiatives such as market expansion and investment in production facilities.
- Summary of cash position and expected future business activities.
- Compliance statements and regulatory disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SSH Group Ltd (SSH) ORDINARY FULLY PAID |
Industrials |
$15 |
Quarterly Activities Report & Appendix 4C Cash Flow Report
|
30 Jul 2025 9:13AM |
$0.145 |
$0.140 |
fallen by
3.45%
|
|
SSH - Price-sensitive ASX Announcement
Full Release
Key Points
- SSH Group Ltd continues to provide workforce management and business services.
- The company reported progress in client and revenue growth during the quarter.
- Updates on key contracts and business development activities were disclosed.
- Strategic initiatives to improve operational efficiency and expand capabilities are ongoing.
- Financial data for the quarter, including cash flow and balance statements, were presented.
- Risks, compliance with ASX Listing Rules, and related party transactions were addressed.
- The company commented on its funding position and going concern assessment.
- Future outlook and business strategy focus on increasing market share and operational resilience.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pinnacle Minerals Limited (PIM) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - PIM
|
30 Jul 2025 9:12AM |
$0.040 |
$0.050 |
risen by
25%
|
|
| Pinnacle Minerals Limited (PIM) ORDINARY FULLY PAID |
Materials |
$6 |
Placement to Raise $1.76 Million
|
30 Jul 2025 9:12AM |
$0.040 |
$0.050 |
risen by
25%
|
|
PIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Pinnacle Minerals Limited launched a placement to raise $1.76 million.
- Funds will be used to progress Canadian lithium projects and Western Australian kaolin projects.
- Significant support was received from shareholders, directors, and new investors.
- Proceeds to fund exploration, project development, and general working capital needs.
- The placement strengthens the company’s financial position and supports its growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$161 |
Notice of Annual General Meeting/Proxy Form
|
30 Jul 2025 9:12AM |
$0.910 |
$0.410 |
fallen by
54.95%
|
|
| G50 Corp Limited (G50) ORDINARY FULLY PAID |
Materials |
$132 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:11AM |
$0.270 |
$0.645 |
risen by
138.89%
|
|
G50 - Price-sensitive ASX Announcement
Full Release
Key Points
- G50 Corp Limited released its Quarterly Activities/Appendix 5B Cash Flow Report for the quarter ended 31 March 2023.
- The report covers exploration and development activities, operational updates, and financial highlights.
- Key focus was on advancing flagship projects and maintaining strong financial discipline.
- Detailed cash flow statements provided, outlining inflows and outflows for the quarter.
- The company reported on capital raising, project expenditures, and funding strategies.
- Updates on project milestones and operational achievements were included.
- The document discusses the company’s cash position at the end of the reporting period.
- Corporate activities and significant events during the quarter are summarized.
- Commitment to prudent financial management and sustainable operation is emphasized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$26 |
MX1 - Supply Agreement with Major US Healthcare Provider
|
30 Jul 2025 9:11AM |
$0.062 |
$0.035 |
fallen by
43.55%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Micro-X Limited signed a five-year supply agreement with a major US healthcare provider.
- The agreement covers the supply, service, and support of MX1 mobile X-ray systems.
- The healthcare provider's network includes over 2,000 hospitals and clinics across the US.
- The agreement is expected to generate approximately A$20 million in revenue over five years.
- An initial purchase order for 100 MX1 units has been received.
- The partnership marks a key milestone in Micro-X’s US market expansion strategy.
- MX1 was selected for its innovative design and capability to meet the provider's needs.
- The agreement covers logistics, installation, training, and after-sales service.
- Micro-X aims to strengthen its position as a leader in mobile X-ray technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$56 |
Neurizon Secures Loan Against 2025 R&D Tax Rebate
|
30 Jul 2025 9:10AM |
$0.170 |
$0.073 |
fallen by
57.06%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon Therapeutics Limited (NUZ) secures a $3.25 million loan facility from Invest Victoria.
- The loan is backed by the State Government of Victoria and secured against the expected 2025 R&D tax incentive rebate.
- Funding is non-dilutive, preserving shareholder value.
- Proceeds will be used to advance Neurizon's CNS drug development pipeline and ongoing research activities.
- Facility strengthens Neurizon's financial position and supports progression of clinical trials.
- Leverages Australian government R&D tax incentive program to enhance funding.
- No new equity issued, avoiding shareholder dilution.
- Loan ensures continued progress on key research and development programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green360 Technologies Limited (GT3) ORDINARY FULLY PAID |
Materials |
$38 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:09AM |
$0.030 |
$0.029 |
fallen by
3.33%
|
|
GT3 - Price-sensitive ASX Announcement
Full Release
Key Points
- GT3 advanced the Green Hydrogen Ammonia Project during the quarter.
- Engaged consultants and continued technical and commercial project development.
- Maintained discussions with government and industry partners regarding project support and offtake.
- Explored new opportunities within the green energy sector.
- Managed cash flows with a closing balance of approximately $2.2 million.
- Reported total net cash outflows of $0.6 million for the quarter.
- No new mining tenements acquired or disposed during the quarter.
- Confirmed compliance with ASX Listing Rule 5.3.5 regarding related party payments.
- Continued focus on project advancement and strategic partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:09AM |
$0.005 |
$0.002 |
fallen by
60%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of gas production from the Vali gas field, Vintage Energy’s first producing asset.
- Works underway to optimize Vali’s production and further development planning.
- Progress made on the Odin gas field project, including tie-in preparation and future commercialization.
- Exploration activities continued in various permits, with updates on permit applications and approvals.
- Quarterly financial summary includes cash receipts from customers, operating payments, and cash at period end.
- Focus on increasing reserves, production, and prudent management of capital.
- Continued evaluation of new business opportunities to support growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$20 |
June 2025 Quarterly Activities and Cashflow Report
|
30 Jul 2025 9:08AM |
$0.066 |
$0.077 |
risen by
16.67%
|
|
PUR - Price-sensitive ASX Announcement
Full Release
Key Points
- The Warrior Project saw continued exploration with drilling campaigns and geophysical surveys.
- Assay results from drilling indicate potential for nickel, copper, PGEs, and gold mineralisation.
- The Calingiri West Project advanced with target generation and tenement applications.
- Corporate activities included ongoing funding and partnership discussions.
- The cash flow report details exploration and administrative expenditures.
- The company maintains a sound financial position with adequate funds for planned activities.
- Future work includes further drilling, assays, and advancing exploration targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$71 |
Quarterly Activities Report & Appendix 4C - 30 June 2025
|
30 Jul 2025 9:08AM |
$0.009 |
$0.375 |
risen by
4,066.67%
|
|
BLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued progress in the commercialisation of GaN laser diode technology
- Increased customer engagement and product deliveries in the quarter
- Scaling of manufacturing capabilities and supply chain enhancements
- Entry into new market segments for laser diode applications
- Receipt of cash from product sales, government grants, and R&D tax incentives
- Ongoing investment in research, development, and capital equipment
- Outlined operational expenditures and cash flow management strategies
- Strategic initiatives to drive future growth and innovation
- Commitment to developing leading photonics solutions
- Summarised corporate and financial position at the end of the quarter
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| G11 Resources Limited (G11) ORDINARY FULLY PAID |
Materials |
$32 |
G11 June 2025 Quarterly Activities Report & Appendix 5B
|
30 Jul 2025 9:07AM |
$0.014 |
$0.220 |
risen by
1,471.43%
|
|
G11 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities focused on exploration and operational advancements.
- Progress reported on drilling, sampling, and exploration at core projects.
- Updates provided on tenement status and regulatory compliance.
- Financial summary included with details on cash flow and expenditure.
- Material developments highlighted for the reporting period.
- Emphasis on maintaining strong corporate governance.
- Reminder of compliance with ASX listing and disclosure rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adelong Gold Limited (ADG) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:06AM |
$0.006 |
$0.005 |
fallen by
9.09%
|
|
ADG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities until 31 March 2024.
- Continued focus on exploration, resource development, and production at Adelong Gold Project.
- Drilling and metallurgical test work aimed at increasing gold recovery and resource definition.
- Operational improvements and cost controls implemented at the processing plant.
- Financial summary includes exploration expenditure and cash position at quarter end.
- Company is seeking additional funding to support ongoing and future projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$31 |
June 2025 Quarterly Activities and Cashflow Report
|
30 Jul 2025 9:05AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
RIM - Price-sensitive ASX Announcement
Full Release
Key Points
- The company advanced exploration at its Avondale, Fifield, and Valley projects in NSW.
- Focus remained on scandium, cobalt, gold, and critical minerals.
- Significant soil sampling and drilling activities were completed, especially at Avondale.
- New gold anomalies were identified at the Fifield project.
- The company managed expenses to maintain a stable cash position.
- Partnerships and grant applications were pursued to support exploration and resource definition.
- No mining production occurred during the period; the focus was solely on exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thor Energy Plc (THR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$10 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:05AM |
$0.008 |
$0.010 |
risen by
25%
|
|
THR - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling programs were conducted at the Wedding Bell and Radium Mountain uranium projects in Colorado, targeting high-priority zones and returning intercepts of uranium mineralization.
- Geophysical and geochemical surveys continued at the Alford East copper-gold project in South Australia, with results supporting further drilling and project development.
- The Molyhil tungsten-molybdenum project in the Northern Territory underwent a review of mineral resource estimates and metallurgical testing.
- Thor Energy maintains a strong focus on uranium, copper, and gold exploration within its portfolio.
- Cash outflows during the quarter primarily related to exploration and evaluation activities.
- The company ended the quarter with a cash balance of approximately A$2.2 million, and reported no significant changes to equipment or tenements.
- No mining production or development activities were reported during the quarter; the company remains in the exploration and evaluation phase.
- The Appendix 5B report confirms expenditures and provides disclosures on related party payments and anticipated future spending.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hudson Investment Group Limited (HGL) ORDINARY FULLY PAID |
Real Estate |
- |
Quarterly Report and Activity Statement
|
30 Jul 2025 9:04AM |
$0.175 |
$0.175 |
fallen by
0%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$42 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 9:03AM |
$0.024 |
$0.034 |
risen by
41.67%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported quarterly activities and Appendix 4C Cash Flow for the quarter ending 30 June 2023.
- Achieved growth in annual recurring revenue from SaaS subscription sales.
- Expanded into new markets and continued product development.
- Focused on clinical and workplace solutions via wearable sensor technology.
- Delivered products through both direct and channel sales models.
- Received customer cash receipts and managed costs effectively.
- Secured grant funding to support business growth and innovation.
- Reported prudent cash flow management and maintained sufficient cash reserves.
- Provided a financial summary in line with ASX listing requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$31 |
Firebird to Develop Lithium Manganese Rich Cathode
|
30 Jul 2025 9:03AM |
$0.125 |
$0.170 |
risen by
36%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebird Metals Limited has developed a lithium-manganese-rich (LMR) cathode using its own supply chain.
- The LMR cathode was produced from battery-grade HPMSM sourced from Firebird’s wholly-owned subsidiary in China.
- The cathode material demonstrated high electrochemical performance and cycle stability.
- This innovation enables Firebird to target the expanding market for lithium-ion batteries, especially for EVs and energy storage.
- The LMR cathode is part of Firebird’s strategy to vertically integrate its battery materials business.
- Firebird has commenced pilot production runs and is working on scaling up manufacturing capabilities.
- The company is pursuing partnerships and market entry strategies in China and internationally.
- The announcement positions Firebird as a new player in the advanced battery materials sector with upstream supply chain control.
- Firebird’s LMR cathode development supports its goal of building a new energy material ecosystem.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 9:03AM |
$0.018 |
$0.012 |
fallen by
33.33%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- The company is advancing its portfolio of topical and transdermal pharmaceutical products.
- Acrux made regulatory submissions in the US and other markets during the quarter.
- Development of pipeline products remained a focus, with progress on multiple projects.
- The company maintained ongoing relationships with commercial and development partners.
- Cash flow summary included research and development expenses, receipts from customers, and other operating costs.
- Acrux reported its cash position and financial outlook remains stable.
- The company continues to focus on regulatory milestones and commercial expansion.
- Management is committed to prudent financial management as it seeks to grow its diversified pharmaceutical portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
